Oncology Clinical Researcher

Alignerr Corp.; Wellington; Remote; NZD 83,000 - 138,000; Part time

Job summary

Alignerr is seeking an Oncology Clinical Researcher for a remote, flexible hourly contract focused on AI training with oncology trial data.

You'll design and evaluate trial protocols, assess safety and endpoints, and ensure regulatory alignment with FDA/EMA standards, translating findings into AI-ready insights.

Work asynchronously 10–40 hours/week, contributing to high-impact cancer research on your own schedule.

Qualifications

• Experience designing oncology clinical trials from protocol through data readout.
• Strong ability to analyze clinical oncology data including endpoints and safety profiles.
• Familiarity with regulatory submission standards for FDA/EMA.
• Detail-oriented with a rigorous approach to AI outputs.

Responsibilities

• Design and evaluate oncology trial protocols for AI training workflows.
• Analyze cancer trial data including safety, efficacy endpoints, and biomarkers.
• Translate trial outcomes into regulatory and scientific frameworks aligned with FDA/EMA standards.
• Review AI-derived clinical insights for accuracy and regulatory alignment.
• Ensure AI systems reflect real-world regulatory and clinical standards.

Skills

Trial design

Regulatory compliance

Data analysis

Biomarker analysis

FDA/EMA submissions

Job description

Oncology Clinical Researcher (AI Training)

What if your deep expertise in cancer clinical trials could directly shape how AI understands and reasons about oncology — influencing the future of cancer research and treatment at scale?

We're looking for experienced Oncology Clinical Researchers to bring real‑world scientific and regulatory rigor to cutting‑edge AI development. You'll work alongside leading AI research teams to ensure the oncology data powering next‑generation AI models reflects the highest standards of clinical accuracy, regulatory compliance, and scientific integrity.

This is a fully remote, flexible contract role built for experienced oncology professionals who want to contribute to something genuinely transformative — on their own schedule.

• Organization: Alignerr
• Type: Hourly Contract
• Location: Remote
• Commitment: 10–40 hours/week

What You'll Do

• Design and evaluate oncology clinical trial protocols — bringing your expertise in patient enrollment, regulatory compliance, and study design to AI training workflows
• Analyze cancer trial data including safety profiles, efficacy endpoints, and biomarker results to assess treatment performance and clinical relevance
• Translate trial outcomes into clear regulatory and scientific frameworks aligned with FDA/EMA submission standards
• Review and critique AI-generated clinical insights for accuracy, scientific validity, and regulatory alignment
• Help ensure that AI systems reasoning about oncology data reflect real‑world clinical and regulatory standards
• Work independently and asynchronously — fully on your own schedule

Who You Are

• Experienced in designing and managing oncology clinical trials from protocol development through data readout
• Strong background in analyzing clinical oncology data — including primary and secondary endpoints, safety profiles, and biomarkers
• Familiar with regulatory submission standards for agencies such as the FDA or EMA
• Detail‑oriented and rigorous — you hold clinical AI outputs to the same standards you'd apply to real-world research
• Self‑motivated and comfortable working independently without day‑to‑day supervision

Nice to Have

• Prior experience with data annotation, data quality evaluation, or AI model assessment
• Background in oncology‑specific regulatory affairs or clinical operations
• Experience writing or reviewing clinical study reports, IND/NDA submissions, or publications
• Familiarity with AI tools or evaluation platforms as an end user

Why Join Us

• Work directly on frontier AI systems that are transforming how the world approaches cancer research
• Fully remote and flexible — work when and where it suits you
• Freelance autonomy with the substance of meaningful, high‑impact scientific work
• Contribute to AI development that could reshape clinical decision‑making and cancer treatment globally
• Potential for ongoing work and contract extension as new projects launch